Medical abortion at 13 or more weeks gestation provided through telemedicine: A retrospective review of services
- PMID:33615210
- PMCID: PMC7881210
- DOI: 10.1016/j.conx.2021.100057
Medical abortion at 13 or more weeks gestation provided through telemedicine: A retrospective review of services
Abstract
Objectives: To evaluate medical abortion effectiveness and safety in women at 13 or more weeks gestation provided care through Women on Web's telemedicine service.
Study design: We conducted a retrospective case study of abortions at 13 or more weeks gestation provided by Women on Web between 2016 and 2019. Women received mifepristone and misoprostol or misoprostol alone for abortion. We extracted demographic characteristics and outcome data for cases with pregnancy continuation outcomes.
Results: We identified 144 women who used medical abortion at 13 or more weeks; 131 (91%) provided abortion outcome data. Almost all, 118 (90%) received mifepristone and misoprostol. The population had an average age of 26 ± 5.8 years, 102 (78%) reported a gestational age of 13 to 15 weeks, 114 (87%) had experienced prior pregnancy, and represented all world regions. Overall, 13 (10%) women reported a continuing pregnancy, with 5 (5%) among women 13 to 15 weeks and 8 (28%) among those ≥16 weeks (p = 0.001); 38 (29%) reported adverse events (heavy bleeding, fever), 53 (43%) sought additional care from a health provider, and 18% of all cases received treatment with D&C/aspiration.
Conclusions: Efficacy of self-administered medical abortion decreases as gestational age increases, risking continuation of pregnancy. Provision through telemedicine at 13 to 15 weeks appears safe and effective.
Implications: Limited data suggest that medical abortion through telemedicine services may be a safe option through 15 weeks gestation in settings where there is ready access to the formal health system. More research with adequate sample sizes and high rates of follow-up is needed to inform on the safety of telemedicine for pregnancies 13 weeks and greater.
Keywords: Abortion; Second trimester abortion; Self-management of medical abortion; Telemedicine.
© 2021 The Author(s).
Similar articles
- Provision of medical abortion using telemedicine in Brazil.Gomperts R, van der Vleuten K, Jelinska K, da Costa CV, Gemzell-Danielsson K, Kleiverda G.Gomperts R, et al.Contraception. 2014 Feb;89(2):129-33. doi: 10.1016/j.contraception.2013.11.005. Epub 2013 Nov 12.Contraception. 2014.PMID:24314910
- Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: A retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador.Moseson H, Bullard KA, Cisternas C, Grosso B, Vera V, Gerdts C.Moseson H, et al.Contraception. 2020 Aug;102(2):91-98. doi: 10.1016/j.contraception.2020.04.015. Epub 2020 Apr 30.Contraception. 2020.PMID:32360817
- Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.Aiken ARA, Digol I, Trussell J, Gomperts R.Aiken ARA, et al.BMJ. 2017 May 16;357:j2011. doi: 10.1136/bmj.j2011.BMJ. 2017.PMID:28512085Free PMC article.
- Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.Chen MJ, Creinin MD.Chen MJ, et al.Obstet Gynecol. 2015 Jul;126(1):12-21. doi: 10.1097/AOG.0000000000000897.Obstet Gynecol. 2015.PMID:26241251Review.
- Medical methods for first trimester abortion.Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A.Kulier R, et al.Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3.Cochrane Database Syst Rev. 2004.Update in:Cochrane Database Syst Rev. 2011 Nov 09;(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.PMID:15106180Updated.Review.
Cited by
- Medication abortion via digital health in the United States: a systematic scoping review.Kumsa FA, Prasad R, Shaban-Nejad A.Kumsa FA, et al.NPJ Digit Med. 2023 Jul 12;6(1):128. doi: 10.1038/s41746-023-00871-2.NPJ Digit Med. 2023.PMID:37438435Free PMC article.
- Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients.Akinyemi A, Owolabi OO, Erinfolami T, Stillman M, Bankole A.Akinyemi A, et al.Front Glob Womens Health. 2022 Aug 17;3:899662. doi: 10.3389/fgwh.2022.899662. eCollection 2022.Front Glob Womens Health. 2022.PMID:36060610Free PMC article.
- Addressing the urgent global need for later abortion care during COVID-19 and beyond.Kapp N, Edelman A, Gomperts R, Srinivasan K, Dabash R.Kapp N, et al.BMJ Sex Reprod Health. 2021 Oct;47(4):e15. doi: 10.1136/bmjsrh-2020-200945. Epub 2021 Jan 27.BMJ Sex Reprod Health. 2021.PMID:33504511Free PMC article.No abstract available.
- Abortion in Countries with Restrictive Abortion Laws-Possible Directions and Solutions from the Perspective of Poland.Zaręba K, Herman K, Kołb-Sielecka E, Jakiel G.Zaręba K, et al.Healthcare (Basel). 2021 Nov 20;9(11):1594. doi: 10.3390/healthcare9111594.Healthcare (Basel). 2021.PMID:34828639Free PMC article.Review.
References
- World Health Organization . World Health Organization; Geneva: 2012. Safe Abortion: Technical and Policy Guidance for Health Systems. - PubMed
- World Health Organization . World Health Organization; Geneva: 2018. Medical Management of Abortion.
- World Health Organization . Geneva; 2015. Health worker roles in providing safe abortion care and post-abortion contraception. - PubMed
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources